Company intelligence / Profile preview

Novabiosis

Research Triangle Park, North Carolina, United Statesnovabiosis.com ↗

Ownership: Private
Development stage: Commercial

Overview

Novabiosis provides cryopreserved primary human cell types from multiple organ sources to support academic, biotech, pharmaceutical, and medical research. It works with US Organ Procurement Organizations to source non-transplantable organs for isolation of high-quality primary cells. Its offerings include hepatocytes and other liver cell types, kidney glomerular endothelial cells and podocytes, lung fibroblasts/epithelial cells, intestinal myofibroblasts among others. The company's products are used in preclinical R&D across various disease areas.

Modalities: Primary human cellsCryopreserved primary cells
Industry: Chemicals & Materials

Partnerships

Extensive partnerships with US Organ Procurement Organizations (OPOs)Zen-Bio (for custom isolations)

Beyond the preview

Go deeper on Novabiosis.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novabiosis.

Explore the full profile